Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
menstrual blood-derived mesenchymal stem cells (S-Evans Biosciences)
- Development stage
- Unknown
- Lead developer
- S-Evans Biosciences
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intra-arterial
01
Overview
Menstrual blood-derived mesenchymal stem cells (MenSCs) is an investigational cell therapy developed by S-Evans Biosciences for the treatment of type 1 diabetes mellitus. These mesenchymal stem cells are isolated from menstrual blood, providing a non-invasive and ethically uncomplicated source of multipotent cells characterized by high proliferation rates and the ability to differentiate into various cell lineages. The therapy is hypothesized to function through immunomodulation and the promotion of endogenous pancreatic progenitor cell differentiation, thereby improving glycemic control and potentially regenerating or preserving beta-cell function. It has been evaluated in Phase 1/2 clinical trials involving intravenous or intra-arterial (pancreatic artery) administration.
- Other names
- Menstrual blood-derived stem cellsMenstrual blood-derived mesenchymal stem cells
Beyond the preview
Go deeper on menstrual blood-derived mesenchymal stem cells (S-Evans Biosciences).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on menstrual blood-derived mesenchymal stem cells (S-Evans Biosciences).